Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+၀.၂၁%
၁,၀၉၆.၁၂
+၂.၃၁
+၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၃.၂၀——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၄၅%
၆၁၁.၄၈
+၂.၇၁
+၀.၄၅%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၀၆%
၁,၂၄၁.၅၀
-၁၃.၃၁
-၁.၀၆%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၅၈%
၁,၇၅၀.၈၁
-၁၀.၃၀
-၀.၅၈%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၅.၃၉——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၀၂%
၆၄၂.၄၈
-၀.၁၀
-၀.၀၂%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၁.၄၀——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၅%
၈၄၉.၈၅
-၁.၂၈
-၀.၁၅%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၁၅%
၂၁၇.၆၅
-၀.၃၃
-၀.၁၅%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၇၃%
၃,၂၆၇.၃၄
+၅၅.၅၁
+၁.၇၃%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၇.၇၆၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၃၇%
၉၄၅.၅၆
-၃.၄၂
-၀.၃၇%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၃၂%
၁,၄၆၉.၈၅
-၄.၆၇
-၀.၃၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၉.၁၇——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၆၀%
၂,၄၀၆.၅၂
+၁၄.၄၀
+၀.၆၀%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
CRL:NYSE
Charles River Lbrtrs ntrntl Inc
၁၆၅.၉၈ US$
-၀.၅၂%
(-၀.၈၆) 1D
မေ ၁, GMT-၄ ၁၅:၃၇:၁၈  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRL...
Open
၁၆၇.၆၆ US$
High
၁၆၇.၆၆ US$
Low
၁၆၃.၁၀ US$
Mkt. cap
၈၁၈.၉၈ ဋေ
Avg. vol.
၈.၄၇ သိန်း
Volume
၂.၉၀ သိန်း
52-wk high
၂၂၈.၈၈ US$
52-wk low
၁၀၇.၆၀ US$
EPS
-၂.၉၁ US$
Beta
၁.၆၁
Shares outstanding
၄.၉၃ ကုဋေ
No. of employees
၂ သောင်း
News stories
From sources across the web
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
First commercial rat IVF service targets breeding bottlenecks
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors
Profile
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients. Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs. As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
About Charles River Lbrtrs ntrntl Inc
CEOJames C. Foster
Employees၁.၉ သောင်း
Founded၁၉၄၇
HeadquartersWilmington, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitecriver.com
Next call ၆ ရက်အတွင်း
မေ ၇ ကြာသပတေး, ၈:၃၀
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (၁.၉၄ est.)USD
Revenue / Estimate
-/ (၉၇.၇၇ ကုဋေ est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၉၈.၄၂ ကုဋေ
၁၀၃.၂၁ ဋေ
၁၀၀.၄၉ ဋေ
၉၉.၄၂ ကုဋေ
Cost of goods sold
၆၄.၄၁ ကုဋေ
၆၄.၈၆ ကုဋေ
၆၅.၂၇ ကုဋေ
၆၆.၅၄ ကုဋေ
Cost of revenue
၆၄.၄၁ ကုဋေ
၆၄.၈၆ ကုဋေ
၆၅.၂၇ ကုဋေ
၆၆.၅၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၇.၆၃ ကုဋေ
၁၈.၅၈ ကုဋေ
၁၇.၃၆ ကုဋေ
၁၉.၂၀ ကုဋေ
Operating expense
၂၀.၆၁ ကုဋေ
၂၁.၁၅ ကုဋေ
၂၀.၁၀ ကုဋေ
၂၈.၄၀ ကုဋေ
Total operating expenses
၈၅.၀၂ ကုဋေ
၈၆.၀၁ ကုဋေ
၈၅.၃၈ ကုဋေ
၉၄.၉၄ ကုဋေ
Operating income
၁၃.၄၀ ကုဋေ
၁၇.၂၀ ကုဋေ
၁၅.၁၁ ကုဋေ
၄.၄၈ ကုဋေ
Other non operating income
-၃.၆၁ သန်း
၁.၅၄ သိန်း
-၂.၂၆ ကုဋေ
၂.၇၇ ကုဋေ
EBT including unusual items
၃.၆၀ ကုဋေ
၇.၁၄ ကုဋေ
၈.၇၂ ကုဋေ
-၂၉.၄၁ ကုဋေ
EBT excluding unusual items
၉.၅၃ ကုဋေ
၁၄.၃၃ ကုဋေ
၁၀.၄၅ ကုဋေ
၃.၅၂ ကုဋေ
Income tax expense
၁.၀၁ ကုဋေ
၁.၈၇ ကုဋေ
၃.၁၆ ကုဋေ
-၁.၇၈ ကုဋေ
Effective tax rate
၂၈.၀၇%
၂၆.၂၂%
၃၆.၂၉%
၆.၀၆%
Other operating expenses
-
-
-
-
Net income
၂.၅၅ ကုဋေ
၅.၂၃ ကုဋေ
၅.၄၄ ကုဋေ
-၂၇.၆၆ ကုဋေ
Net profit margin
၂.၅၉%
၅.၀၇%
၅.၄၂%
-၂၇.၈၂%
Earnings per share
၂.၃၄
၃.၁၂
၂.၄၃
၂.၃၉
Interest and investment income
၁.၄၀ သန်း
၁.၁၀ သန်း
၁.၄၂ သန်း
၁.၀၂ သန်း
Interest expense
-၂.၇၉ ကုဋေ
-၃.၀၀ ကုဋေ
-၂.၅၄ ကုဋေ
-၂.၃၈ ကုဋေ
Net interest expenses
-၂.၆၅ ကုဋေ
-၂.၈၉ ကုဋေ
-၂.၄၀ ကုဋေ
-၂.၂၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၂၁.၈၉ ကုဋေ
၃၂.၇၀ ကုဋေ
၁၆.၅၂ ကုဋေ
၁၆.၉၆ ကုဋေ
Gain or loss from assets sale
-၃.၃၈ သန်း
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer